1 / 26

PPH at NW

PPH at NW. Post partum haemorrhage. Good at identifying low risk women. Syntocinon vs Syntometrine. PPH at NW. Primary PPH rate (>500ml) was 36% 16% with vaginal delivery 78% for emergency caesarean section Role to audit blood loss by staff member?.

brent-ortega
Download Presentation

PPH at NW

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PPH at NW

  2. Post partum haemorrhage

  3. Good at identifying low risk women

  4. Syntocinon vs Syntometrine

  5. PPH at NW • Primary PPH rate (>500ml) was 36% • 16% with vaginal delivery • 78% for emergency caesarean section • Role to audit blood loss by staff member?

  6. Individual audit at an Australian public hospital • Registrars advised that a: • Junior (ITP) with a mean blood loss >500ml would result in borderline for surgical skills on assessment form and mean >600ml a fail. • Senior registrar with a mean blood loss >400ml would result in borderline for surgical skills on assessment form and mean >500ml a fail. • Consultants (Lead maternity care providers) were advised they would be audited against background rates. Quinlivan JA et al, Unpublished data JHC Q&S, 2011

  7. Dear Dr Smith,Comment: Your PPH results are significantly poorer than our benchmark.

  8. PPH at JHC 2011 6 months Quinlivan JA et al, Unpublished data JHC Q&S, 2011

  9. Misopristol • Lancet RCT of 1422 women. • Randomised to Misopristol or Placebo. • No difference in rate of PPH (>500ml loss). • More women receiving Misopristol had shivering(65% vs 32%) and a body temperature >380C(43% vs 15%). • Findings do not support the use of Misopristol in addition to standard uterotonics for treatment of PPH. Widmer M et al. Lancet 2010; 375: 1808-

  10. NW Strategies to reduce PPH • New guidelines for PPH late 2009 • Expected to result in an increased use of syntometrinefor prevention of PPH in women at risk and a more consistent approach to calling for help. • Overall reduction in blood transfusion 3.3% (2009) to 2.6% (2010). • New checklist for PPH in 2010 • Hospital wide strategy to reassess need for a second bag of blood.

  11. Other strategies to consider... • Delivery suite: • Ensure routine active management strategies are being implemented correctly • Ensure PPH is being recognised early • Axe use of Misopristol • Audit PPH rate by LMC provider for SVD and give feedback. • Operating theatre: • Consider using a long acting syntocinon • Audit PPH rate by LMC provider and registrar for CS and give feedback.

  12. Induction of Labour

  13. IOL at NW • More than 1 in 3 nulliparous women were induced. • Post dates pregnancy and term PROM were the most common reasons for IOL • When post dates was the primary reason for IOL, 11% occurred BEFORE 41 weeks gestation.

  14. Diagnosis of term PROM • Need to confirm diagnosis through history, examination and testing (amnicator/ultrasound). • Consider waiting 24 hours if GBS negative.

  15. Post dates IOL • Restrict access to postdates IOL until AFTER 41 weeks. • Ensure dates are confirmed by early USbefore booking. • Introduce offer of routine membrane sweepingat 38 and 39 weeks to reduce post dates IOL.

  16. Sweeping membranes • Meta analysis of RCT concluded that a policy of offering routine sweeping of membranes at 38 or 39 weeks reduces the number of women progressing to post term gestation and the need for formal labour induction. • Boulvain M eta al. Cchrane database of systematic reviews 2005; CD000451.

  17. Urogynaecology

  18. Urogynaecology • 209 had urogynaecology procedure. • 40 women had a hysterectomy at the same time as their urogynaecology procedure. • Complication rate was 10.5% overall

  19. Urogynaecology complications

  20. Urogynaecology and Prolapse • 300,000 operations performed annually in US. • Sacrocolpopexy considered the gold-standard. • Vaginal approach to prolapse repair common. • Surgical outcomes for vaginal native tissue repair of prolapse are poor • Nearly 1 in 3 womenundergo repeat surgery. • Lifetime risk of reoperation • Mean interval to reoperation was 12.5 years. • Clark AL. AJOG 2001; 184: 1357-1364.

  21. Should you be using Vaginal mesh outside a trial setting? Rogers RG, Obstet Gynecol 2011; 118: 1-2

  22. Concern over use of vaginal mesh • Prompted by adverse reports, in October 2008 FDA issued safety advisory regarding the use of mesh for treatment of incontinence and vaginal prolapse. • Issued advice that more detailed information to be collected. • New FDA advisory released July 2011 states that there are serious concerns over the use vaginal mesh for the treatment of vaginal prolapse and incontinence.

  23. FDA Advisory • “The occurrence of serious complications with the use of vaginal mesh is not rare and mesh use is not proven to provide improved outcomes when compared with native tissue repairs.” • “Update prompted by an increase in the number of reports made to the Manufacturer and User Facility Device Experience database, including common reports of exposure, erosion, and protrusion of mesh into the vagina and new reports of mesh contractions.” • US Food & Drug Administration 2011

  24. How are devices cleared? • FDA • Class I (low risk) • Class II (Mesh, contact lens solution, external hearing aid) • Class III (high risk) • Process • Premarket approval required (Clinical trials required - expensive) • 510k process which clears for market (does not approve) • Withdrawal from market 2005 to 2009 • 113 items withdrawn or recalled • 71% were Class II, 510k devices!

  25. Some excellent results • General • Breast feeding • Quit campaign • Low complication rates in • General Gynaecology • Gynaecology Oncology • Obstetrics • HIE (below benchmark) • VBAC (above benchmark)

  26. Thankyou

More Related